Prowill Pharmaceuticals Private Limited - Company Profile

It is a pharma private limited company based in Navi Mumbai, Maharashtra, India, established in 2012.
2012 Navi Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Prowill Pharmaceuticals Private Limited

Prowill Pharmaceuticals Private Limited, a active private limited company, was established on 30 March 2012 in Navi Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U74999MH2012PTC229057. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹5.16 Cr and a paid-up capital of ₹4.75 Cr.

It upholds a compliant status. Employing 9 professional, Its leadership includes Santosh Shrikrishna Joshi (Director), Varsha Santosh Joshi (Director). Past directors included Suhas Ramesh Ghuge, Dagadu Ganpat Bansode, Santosh Shrikrishna Joshi. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at J. P. House, Plot No. D--28/16, M.I.D.C., T.T.C. Industrial Area, Turbhe, Navi Mum, Bai, Navi Mumbai, Maharashtra, 400705.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74999MH2012PTC229057

  • Registration Number

    229057

  • Incorporation Date

    30 March 2012

  • Authorized Capital

    ₹5.16 Cr

  • Paid-Up Capital

    ₹4.75 Cr

  • ROC Code

    Roc Mumbai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.16 Cr
  • Paid Up Capital ₹ 4.75 Cr
  • Company Age 13 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Revenue Growth **** 46.93%
  • Profit Growth **** 115.02%
  • Ebitda **** 191.43%
  • Net Worth 25.50%
  • Total Assets **** 14.57%
Company report

Prowill Pharmaceuticals Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Prowill Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Prowill Pharmaceuticals Private Limited?
Current Directors
Name Designation Appointment Date Status
Santosh Shrikrishna Joshi Director 17 Jul 2020 Current
Varsha Santosh Joshi Director 18 Jul 2022 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 17 Jul 2020 Past
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Additional Director 31 Dec 2020 Past
Pramod Abcsdd Director 04 Nov 2017 Past
Pramod Abcsdd Additional Director 29 Sep 2017 Past
Pramod Abcsdd Additional Director 30 Sep 2022 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Prowill Pharmaceuticals.

Prowill Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 46.93% increase. The company also saw a substantial improvement in profitability, with a 115.02% increase in profit. The company's net worth Soared by an impressive increase of 25.5%.

Prowill Pharmaceuticals revenue growth over time
Prowill Pharmaceuticals profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 46.93%
*******
*******
*******
*******
Revenue from Operations
*******
 74.08%
*******
*******
*******
*******
Total Assets
*******
 14.57%
*******
*******
*******
*******
Profit or Loss
*******
 115.02%
*******
*******
*******
*******
Net Worth
*******
 25.50%
*******
*******
*******
*******
EBITDA
*******
 191.43%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Prowill Pharmaceuticals?

In 2023, Prowill Pharmaceuticals had a promoter holding of 82.69% and a public holding of 17.31%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Prowill Pharmaceuticals?

Prowill Pharmaceuticals has a workforce of 9 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Prowill Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prowill Pharmaceuticals's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Prowill Pharmaceuticals
Recent Activity within the Organization
  • Annual General Meeting

    The activity Prowill Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.

  • Balance Sheet

    Prowill Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was recorded as a recent event.

  • Director Appointment

    The activity Varsha Santosh Joshi was appointed as a Director was appointed as a Director on 18 Jul 2022 & has been associated with this company since 3 years 7 months . was completed.

  • Director Appointment

    Santosh Shrikrishna Joshi was appointed as a Director was appointed as a Director on 17 Jul 2020 & has been associated with this company since 5 years 7 months . was recorded as a recent event.

  • Company Incorporation

    Progress on Prowill Pharmaceuticals Private Limited was registered on 30 Mar 2012 with Roc Mumbai & aged 13 years 11 months as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Prowill Pharmaceuticals Private Limited?

The CIN of Prowill Pharmaceuticals Private Limited is U74999MH2012PTC229057.

Where is Prowill Pharmaceuticals Private Limited headquartered?

Prowill Pharmaceuticals Private Limited is headquartered at J. P. House, Plot No. D--28/16, M.I.D.C., T.T.C. Industrial Area, Turbhe, Navi Mum, Bai, Navi Mumbai, Maharashtra, 400705.

When was Prowill Pharmaceuticals Private Limited incorporated?

Prowill Pharmaceuticals Private Limited was incorporated on 30 March 2012.

Who are the current directors of Prowill Pharmaceuticals Private Limited?

The current directors of Prowill Pharmaceuticals Private Limited are

What is the primary industry of Prowill Pharmaceuticals Private Limited?

The primary industry of Prowill Pharmaceuticals Private Limited is Manufacturing.

Is Prowill Pharmaceuticals Private Limited a listed company?

Prowill Pharmaceuticals Private Limited is unlisted.

What is the capital structure of Prowill Pharmaceuticals Private Limited?

The authorized capital of Prowill Pharmaceuticals Private Limited is ₹5.16 Cr, and the paid-up capital is ₹4.75 Cr.

What is the compliance status of Prowill Pharmaceuticals Private Limited?

The compliance status of Prowill Pharmaceuticals Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available